$0.5100
At close: Apr 15 EDT
$0.4404
-0.07-13.65%
Pre-Market: 7:54 PM EDT
Comments
Loading...
Impact BioMedical Analyst Ratings and Price Targets | AMEX:IBO | Benzinga
Impact BioMedical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Impact BioMedical Corp from these most-recent analyst ratings.
Analyst Ratings for Impact BioMedical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Impact BioMedical (IBO) stock?
There is no price target for Impact BioMedical
What is the most recent analyst rating for Impact BioMedical (IBO)?
There is no analyst for Impact BioMedical
When was the last upgrade for Impact BioMedical (IBO)?
There is no last upgrade for Impact BioMedical
When was the last downgrade for Impact BioMedical (IBO)?
There is no last downgrade for Impact BioMedical.
When is the next analyst rating going to be posted or updated for Impact BioMedical (IBO)?
There is no next analyst rating for Impact BioMedical.
Is the Analyst Rating Impact BioMedical (IBO) correct?
There is no next analyst rating for Impact BioMedical.
Browse analyst ratings and price targets on all stocks.